


































The discovery of epidermal growth factor 
 
Many diverse functional roles for Epidermal Growth 
Factor (EGF) have been uncovered since its discovery 
by Stanley Cohen more than half a century ago [1].   
Cohen had noted that the injection of crude 
submaxillary gland preparations into newborn mice 
resulted in increased epidermal growth and 
keratinization, triggering the premature opening of the 
eyelid [1, 2].  Using precocious eyelid opening as a 
bioassay, Cohen isolated and identified EGF as a small 
secreted protein rich in disulphide bonds [3-6].  Latter 
experiments showed that EGF could induce mitosis of 
cultured epidermal cells, promote DNA synthesis, 
stimulate translation, and increase protein 







































for EGF and its downstream signaling components 
ensued. 
 
Our understanding of the function of endogenous EGF 
signaling  in vivo was facilitated by developmental 
genetic studies in several model organisms.  In 
Drosophila, there is a single EGF receptor with multiple 
EGF ligands, and EGF signaling has been implicated in 
embryonic pattern formation, larval disc proliferation, 
and multiple cell fate decisions [10-12].  In C. elegans, 
there is a single gene for EGF, called lin-3, and a single 
gene for its receptor, called let-23, that were originally 
identified based on their role in the induction of the 
nematode vulva from undifferentiated epithelial 
precursor cells [13, 14].  A single anchor cell situated 


















signaling,  emphasizing  several  recent  studies  that  uncovered  an  unexpected  role  for  EGF  in  promoting  longevity  and
healthspan in mature adult C. elegans.  EGF, acting through phospholipase Cγ and the IP3 receptor signaling, maintains
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cell, inducing them to adopt the vulval fate during larval 
development.  Hypomorphic mutations that impair EGF 
signaling result in a failure of vulval fate specification, 
resulting in a vulvaless animal that cannot lay eggs (the 
“bag of worms” phenotype) [15, 16].  EGF is also 
required for larval survival, as a null mutation in the 
EGF receptor (EGFR) results in L1 stage larval lethality 
[17, 18].  Additional functions for EGF include a role in 
reciprocal signaling from the vulval back to the uterus 
to coordinate the development of these connected 
tissues, promotion of male spicule development, and 
induction of P12.p cell fate in the epithelia [18, 19].  In 
addition to being a developmental signal, EGF also acts 
as a physiological signal, promoting ovulatory 
contractions of the gonad sheath cells and inducing a 
reversible nervous system quiescence during each larval 
molt [20, 21]. 
 
EGF signaling can occur through multiple signal 
transduction pathways 
 
A combination of many years of biochemical and 
genetic studies has elucidated several parallel signal 
transduction pathways used by EGF and its receptor 
(Figure 1).  Upon EGF binding, the EGFR becomes 
autophosphorylated, resulting in the recruitment of 
adaptors like Grb2/SEM-5 and activation of the 
Ras/ERK signal transduction cascade [22].  In C. 
elegans, LIN-3/EGF activates LET-60/Ras and MPK-
1/ERK to promote vulval differentiation through the 
modulation of multiple transcription factors [23].   
EGFR activation also stimulates phospholipase C 
gamma (PLCγ) [24, 25], resulting in the production of 
inositol 1,4,5-trisphosphase (IP3) and the release of 
calcium from intracellular stores via the IP3  receptor.  
The C. elegans PLCγ and IP3 receptor are encoded by 
PLC-3 and ITR-1, respectively, and C. elegans uses this 
pathway to promote ovulatory contractions in response 
to LIN-3/EGF [21, 26].  Finally, EGFR activation can in 
turn promote phosphoinositide 3-kinase (PI3K) activity 
either directly, with the p85 regulatory subunit of PI3K 
recognizing the phosphorylated receptor, or indirectly, 
with p85 interacting through a Grb2/GAB complex.   
Activated Ras can also activate the PI3K p110 catalytic 
subunit [27].  Once activated, PI3K converts 
phosphatidylinositol (4,5)-bisphosphate (PIP2) into 
phosphatidylinositol (3,4,5)-triphosphate (PIP3).  PIP3 in 
turn binds the pleckstrin homology (PH) domain of Akt, 
stimulating its kinase activity and promoting the 
phosphorylation of proteins that regulate cell growth, 
cell cycle entry, and cellular survival [28].  This 
includes mammalian target of rapamycin (mTOR), a 
positive regulator of translation [29].  It is unknown 
whether  C. elegans LIN-3/EGF signaling activates 
PI3K (AAP-1, PDK-1, and AGE-1 in C. elegans) or Akt 
(AKT-1 and AKT-2 in C. elegans); however, 
Insulin/IGF Signaling (IIS) has been implicated in 
regulating longevity through PI3K and Akt [30]. 
 
EGF implicated in longevity and healthspan 
 
Several recent studies have implicated a novel function 
for EGF signaling in promoting C. elegans longevity.  
One of these studies was originally prompted from 
analysis of the IIS pathway, another signaling pathway 
long implicated in aging.  Central to the IIS pathway in 
C. elegans is the DAF-2 insulin receptor, which signals 
through the AGE-1 PI3K to inhibit longevity [31].  In 
well-fed animals, DAF-2 becomes activated, triggering 
the phosphorylation of the DAF-16 FOXO transcription 
factor by AKT-1, AKT-2, and SGK-1, which prevents it 
from accumulating in the nucleus [32-36].  By contrast, 
stress or acute nutrient deprivation depresses IIS 
activity, releasing DAF-16/FOXO to enter into the 
nucleus and regulate the transcription of genes involved 
in dauer formation (a diapause state), metabolism, lipid 
storage, stress response, and lifespan extension [37-42].  
While there is a single DAF-2 insulin receptor, there are 
forty putative insulin-like ligands in the C. elegans 
genome, as well as multiple insulin receptor-related 
proteins that are predicted to be secreted molecules [43-
45].  Iwasa et al. recently screened these proteins by 
RNAi-mediated knockdown to identify candidates that 
might have a role in promoting healthy longevity [46].  
Either RNAi-mediated knockdown or deletion 
mutations for two of these genes, named HPA-1 and 
HPA-2 for high performance in old age, resulted in 
increased healthy longevity based on locomotory 
activity, pharyngeal activity, and age-pigment 
accumulation in older animals compared to wild-type 
controls.  While HPA-1 and HPA-2 both contain 
sequences similar to the ligand binding region of the 
insulin receptor, genetic analysis between hpa-1, hpa-2, 
daf-2, and daf-16 mutants indicated that HPA-1 and 
HPA-2, at least in part, normally function to shorten 
healthy lifespan by a mechanism that is independent of 
IIS.  Interestingly, HPA-1 and HPA-2 contain leucine-
rich domains similar to those of mammalian EGFR-
related protein (ERRP), a secreted negative regulator of 
the EGFR, raising the possibility that HPA-1/2 might 
inhibit lifespan by antagonizing the LET-23/EGFR [47].   
Given its multiple roles in cellular growth and early 
development, it is not surprising that EGF had not been 
a major focus of study for a role in lifespan and aging.  
Indeed, many EGF signaling mutants display 
developmental defects that preclude analysis of 
lifespan.  To get around this problem, Iwasa et al. 
examined animals with temperature-sensitive loss of 
function mutations in the LET-23/EGFR and found that  
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later developmental time points [46].  Partial loss of 
function mutations in LIN-3/EGF resulted in a similar 
longevity phenotype.  They also examined animals with 
a gain of function mutation, let-23(sa62), in the 
extracellular domain of LET-23/EGFR that results in 
ligand-independent constitutive activation of the 
receptor [48].  Gain of function let-23 mutants showed 
increased longevity, delayed sarcopenia and age 
pigment accumulation, and healthier locomotion 
behaviors later in life compared to wild-type controls.  
In contrast to the effects of IIS pathway mutations, the 
effects of EGF signaling pathway mutations on lifespan 
were not additive with the effects of RNAi knockdown 
on HPA-1 and HPA-2, consistent with HPA-1/2 
functioning in the EGF signaling pathway, most likely 
by antagonizing EGFR function or EGF/EGFR 
interaction. 
 
Iwasa et al. examined mutations in the different 
signaling pathways downstream of LET-23/EGFR [46].  
RNAi knockdown of LET-60/Ras and MPK-1/ERK did 
not block the extended lifespan observed in let-23(sa62) 
gain of function mutants.  By contrast, either RNAi 
knockdown or mutations in PLC-3/PLCγ or the ITR-
1/IP3 receptor blocked the increase in healthy aging 
observed in let-23(sa62) mutants.  Loss of function and 
gain of function mutations in ITR-1 resulted in reduced 
and enhanced lifespan, respectively, even in the absence 
of let-23(sa62) mutations, indicating that EGF signaling 
promotes healthy aging in C. elegans through activation 
of PLCγ and the IP3 receptor, presumably triggering 
calcium release from internal stores.  It remains unclear 
how accelerated release from internal calcium stores 
could promote longevity, although one possibility could 
be that alterations in ovulation, which are regulated by 
EGF/PLCγ/IP3 signaling in the C. elegans gonad, 
contribute to the observed changes in healthy lifespan 
[49].  Alternatively, elevated cytosolic calcium might 
activate beneficial calcium-dependent pathways that 
promote longevity. 
 
Other branches of the EGF signal transduction pathway 
besides just the PLCγ/IP3 pathway contribute to aging.  
Recently, Okuyama et al. tested for a role for Ras/ERK 
signaling in lifespan regulation [50].  To get around the 
problem of developmental defects, they performed 
RNAi knockdown of LIN-45/RAF, MEK-2/MEK, and 
MPK-1/ERK after animals had reached adulthood.   
Knockdown of these genes, as well as treatment with 
the MEK inhibitor U0126, resulted in a shorter lifespan.  
By contrast, knockdown of LIP-1, a phosphatase that 
normally antagonizes MPK-1/ERK, resulted in lifespan 
extension [51].  One of the phosphorylation substrates 
of mammalian ERK is Nrf2, a transcription factor that 
mediates the antioxidant response during oxidative 
stress [52].  In C. elegans, Nrf2 is encoded by SKN-1, 
which is required for normal lifespan and stress 
resistance [53, 54].  MPK-1/ERK phosphorylates SKN-
1, promoting its activation and nuclear accumulation, 
and knockdown of MPK-1/ERK by RNAi does not 
result in additional lifespan reduction in the absence of 
functional SKN-1, suggesting that Ras/ERK signaling 
can promote lifespan extension, at least in part, through 
activation of SKN-1 and the antioxidant response [50].  
 
EGF regulates protein homeostasis via the Ubiquitin 
Proteasome System 
 
Activation of SKN-1 is not the only way by which EGF 
signaling through Ras/ERK affects lifespan.  Indeed, a 
role for EGF in longevity was also recently 
demonstrated by Liu et al., using a completely different 
approach [55].  These researchers were examining 
protein homeostasis regulation by the Ubiquitin 
Proteasome System (UPS) in C. elegans using an 
Ub
G76V-GFP chimeric reporter for UPS activity.   
Chimeric Ub
G76V-GFP protein contains an amino-
terminal ubiquitin fused in frame with GFP, but with a 
mutation at glycine 76 that prevents the cotranslational 
cleavage that would otherwise release ubiquitin from 
GFP after synthesis [56-58].  The resulting uncleaved 
Ub
G76V-GFP protein mimics a monoubiquitinated GFP 
and is an efficient, non-specific substrate for additional 
polyubiquitination and proteolysis by the 26S 
proteasome.  Ub
G76V-GFP essentially acts as an inverse 
reporter for UPS activity, yielding high GFP 
fluorescence when UPS activity is low and vice versa.  
Liu et al. used different cell-type specific promoters to 
express Ub
G76V-GFP in different C. elegans tissues.   
They noticed that Ub
G76V-GFP levels in larvae remained 
relatively high in epithelia, but that epithelial Ub
G76V-
GFP was rapidly degraded as animals matured into 
fertile adults, suggesting that the steady state levels of 
UPS activity are low during early development, but 
become enhanced at a specific point in adult maturation.  
To identify the biological signal that triggers this 
augmentation in UPS activity in adulthood, they 
undertook a candidate gene approach looking at known 
genes that had been previously implicated in regulating 
protein turnover.  A role for fibroblast growth factor 
(FGF) and Ras/ERK signaling in protein turnover had 
previously been demonstrated in C. elegans body wall 
muscle [59].  Liu et al. found that whereas Ras/ERK 
signaling was required for Ub
G76V-GFP turnover in 
adult epithelia, FGF was not required.  Reasoning that 
the FGF ligand might be specific for muscle, and that 
different tissues might use different signaling ligands to 
regulate UPS activity, they examined EGF signaling 
mutants, including lin-3 and let-23.  Loss of either LIN-
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degradation of Ub
G76V-GFP as animals entered 
adulthood.  By contrast, the let-23(sa62) gain of 
function mutation in the EGFR resulted in precocious 
turnover of Ub
G76V-GFP during larval development.   
Thus, EGF signaling through the Ras/ERK pathway, but 
not through the PLCγ/IP3  pathway, was directing 
protein turnover in adult epithelia. 
 
Using this same candidate gene approach, Liu et al. also 
identified components of the Ubiquitin Fusion 
Degradation (UFD) machinery as being required for 
Ub
G76V-GFP turnover [55].  The UFD is a collection of 
E3 ubiquitin ligases and E4 polyubiquitin extension 
enzymes that recognize protein substrates attached with 
a small chain (1-3 units) of ubiquitin and then catalyze 






































extended polyubiquitin chain that targets the attached 
substrate protein for degradation [57, 60-62].   
Interestingly, Liu et al. found that mutants for multiple 
UFD component genes had a decreased lifespan, similar 
to the lifespan of EGF mutants revealed by Iwasa et al.  
Importantly, mutations in these UFD genes could 
suppress both the lifespan extension and the premature 
UPS activation observed in let-23 gain of function 
mutations.  These findings suggested that EGF pro-
motes longevity by tuning the level of UPS activity at 
different stages of development, presumably having a 
significant impact on protein homeostasis.  The finding 
that Ras/ERK signal transduction is required for EGF to 
activate the UPS strongly suggested that the connection 











































pathway  (e.g.,  nutrient  status,  environmental  stress,  et  cetera),  extracellular  ligands,  transmembrane  receptors,
intracellular  signaling  cascades,  transcription  factors,  and  ultimate  physiological  outputs.  Arrows  indicate  positive
“stimulatory”  genetic  interactions,  whereas  T‐bars  indicate  negative  “repressive”  genetic  interactions.  Dotted  lines
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signaling are known in C. elegans.  Whereas the 
transcriptional targets that mediate vulval differentiation 
do not appear to be required for regulated UPS activity, 
the transcription factors EOR-1 and EOR-2 are essential 
for the activation of the UPS in adults [55].  Indeed, 
mutations in eor-1 completely blocked the accelerated 
UPS turnover observed even in the gain of function let-
23 mutants.  EOR-1 is similar to PLZF, a transcription 
factor implicated in acute promyelocytic leukemia [63, 
64].  Microarray analysis yielded an expression profile 
for EOR-1-regulated genes, including multiple target 
genes involved in the UPS, fat metabolism, and the heat 
shock chaperone response, as well as several genes with 
previously identified roles in regulating longevity 
(several are targets of DAF-16/FOXO). 
 
Interestingly, EGF signaling through EOR-1 results in 
the downregulation of small Heat Shock Proteins 
(sHSPs) of the Hsp16 family [55].  Hsp16 chaperones 
act in the cytosol to prevent the aggregation of 
misfolded and damaged proteins, and appear capable of 
reversing protein aggregation [65-67].  As a 
consequence, mutants defective in EGF/EOR-1 
signaling have elevated Hsp16 chaperone levels and 
thus accumulate aggregates of metastable proteins at a 
slower rate than that of wild type [55].  By contrast, 
mutants with enhanced EGF signaling, like let-23(sa62) 
mutants, have reduced Hsp16 levels and are more 
susceptible to protein aggregation.  Thus, EGF signaling 
affects protein homeostasis by modulating the cellular 
anti-aggregation response. 
 
Concurrently, EGF signaling through EOR-1 also 
results in the upregulation of SKR-5, a Skp1-like 
adaptor protein [55].  Skp1 adaptors act to recruit 
different F-box substrate recognition proteins to Cullin1 
scaffolding molecules, facilitating the formation of 
hundreds of different E3 ubiquitin ligases [68-71].  The 
C. elegans genome contains a single Cullin1 gene and 
21 Skp1-like adaptors [72].  Perhaps the upregulation of 
SKR-5 by EGF/EOR-1 signaling results in the 
activation of multiple different F-box/E3 ubiquitin 
ligase complexes?  Consistent with this possibility, loss 
of function mutations in skr-5 prevent the activation of 
the UPS as animals enter adulthood and have an 
accelerated aging defect similar to that of mutants for 
UFD complex components [55].  Mutations in skr-5 
also block the precocious activation of the UPS and the 
increased longevity observed in let-23(sa62) mutants.   
Whereas upregulation of the SKR-5 adaptor is probably 
not the entire explanation for the activation of the UPS 
in adults, it does suggest that by regulating the 
expression of specific adaptors, cells can change whole 
batteries of different E3 ligases, and hence the stabilities 
of their different target proteins.  In the case of EGF 
signaling, this mechanism might be regulating aging by 
simply increasing the surveillance of oxidized proteins.  
Alternatively, it could be regulating other signaling 
pathways involved in aging.  For example, several E3 
ubiquitin ligases have been implicated in aging through 







































EGF signals a change in strategy for maintaining 
protein homeostasis  
 
Taken together, it would appear that EGF is used as a 
signal not only for tissue morphogenesis during 
development, but for regulating tissue physiology as 
well.  Initially, nematodes use LIN-3/EGF to induce 
epithelia morphogenesis during larval development.  As 
nematodes enter adulthood, their epithelia resynthesize 
LIN-3/EGF, perhaps as an autocrine signal, to trigger 
 
Figure  3.   Environment  and  developmental  timing  to‐
gether  specify  the  physiological  strategy  cells  use  to
maintain protein homeostasis. The left hand column indicates
different  environmental  conditions  that  nematodes  encounter,
ranging from well fed (i.e., abundant nutrients), to acute or sparse
nutrient  availability,  to  more  severe  and  chronic  dietary
restriction.  The  right  hand  columns  show  the  resulting




pathway  respond  to  environmental  conditions  and  to
developmental  timing  so  as  to  coordinate  the  appropriate
physiological response. 
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altering calcium homeostasis, translation, protein 
folding and anti-aggregation, and UPS activity and 
protein turnover (Figure 2).  This represents a strategic, 
genetically programmed switch in cellular physiology 
as animals mature into adulthood, with timing that 
closely parallels the final maturation of the germline, 
suggesting that these two events might be coupled.   
Given the close timing to germline maturity, its 
reasonable to speculate that this EGF-triggered switch 
in physiology might have evolved to maximize 
organismal health at the period of peak fecundity.  If 
this is the case, then the impact of EGF signaling on 
aging might simply be a lucky consequence of 
optimized fitness during young adulthood.  By 
maximizing organismal health during the period of 
fecundity, the animal is able to ward off physiological 
decline associated with aging even long after it has 
depleted its germ cells and fertility no longer matters, 
with the added benefit of extended longevity, at least 
under laboratory conditions. 
 
A number of important questions remain.  What triggers 
the reactivation of LIN-3/EGF expression in adults?  Is 
EGF signaling and UPS upregulation coupled to the 
maturation of the germline?  Or are other developmental 
timing mechanisms involved?  What is it about calcium 
release from internal stores that results in increased 
longevity?  Is the turnover of all proteins affected by 
EGF signaling, or just specific subsets?  What are the 
different F-box proteins that interact with SKR-5 as 
opposed to the other Skp1-like adaptors?  Finally, how 
do the EGF and IIS pathways interact?  There are 
common transcriptional targets between EOR-1 and 
DAF-16, including SKR-5 [41, 55], and EOR-1 
upregulates INS-7, a ligand for DAF-2 with a known 
role in lifespan [80].  In addition, both IIS and EGF 
signaling converge on the transcription factor SKN-1, 
and SKN-1 in turn feeds back on IIS signaling through 
its regulation of INS-39 and DAF-28 [50].  The 
combined pathways, with IIS responding to nutritional 
status and EGF signaling responding to developmental 
timing, together create the physiological state most 
suited for surviving the environment at that stage in life 
(Figure 3).  Future efforts towards understanding how 
these pathways interact will have important implications 
for understanding not only the aging process itself, but 
cancer, neurodegenerative disorders, and other diseases 
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